Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
Scucchi L, Neri B, Sarmati L, Mossa M, Sena G, Massoud R, Petruzziello C, Musumeci M, Marafini I, Calabrese E, Lolli E, Bernardini S, Andreoni M, Monteleone G, Biancone L.
Scucchi L, et al. Among authors: mossa m.
Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2418-2424. doi: 10.26355/eurrev_202103_25283.
Eur Rev Med Pharmacol Sci. 2021.
PMID: 33755981
Free article.